Two Sigma Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-30,162
| Closed | -$3.57M | – | 4818 |
|
|
2021
Q1 | $3.57M | Sell |
30,162
-187,887
| -86% | -$22.2M | 0.01% | 1278 |
|
|
2020
Q4 | $25.8M | Buy |
218,049
+182,455
| +513% | +$21.2M | 0.07% | 297 |
|
|
2020
Q3 | $3.96M | Sell |
35,594
-1,598
| -4% | -$172K | 0.01% | 917 |
|
|
2020
Q2 | $3.8M | Buy |
+37,192
| New | +$3.98M | 0.02% | 775 |
|
|
2018
Q1 | – | Sell |
-44,704
| Closed | -$3.52M | – | 3807 |
|
|
2017
Q4 | $3.52M | Buy |
44,704
+24,826
| +125% | +$2.06M | 0.01% | 1077 |
|
|
2017
Q3 | $1.83M | Buy |
+19,878
| New | +$1.91M | 0.01% | 1351 |
|
|
2017
Q2 | – | Sell |
-3,541
| Closed | -$355K | – | 3497 |
|
|
2017
Q1 | $355K | Buy |
+3,541
| New | +$378K | ﹤0.01% | 2503 |
|
|
2016
Q2 | – | Sell |
-59,034
| Closed | -$6.76M | – | 3437 |
|
|
2016
Q1 | $6.76M | Buy |
59,034
+45,934
| +351% | +$5.39M | 0.03% | 596 |
|
|
2015
Q4 | $1.87M | Sell |
13,100
-96,974
| -88% | -$11.2M | 0.01% | 1121 |
|
|
2015
Q3 | $9.89M | Buy |
110,074
+63,821
| +138% | +$6.74M | 0.05% | 368 |
|
|
2015
Q2 | $5.33M | Sell |
46,253
-9,630
| -17% | -$1.01M | 0.02% | 698 |
|
|
2015
Q1 | $5.34M | Buy |
55,883
+18,631
| +50% | +$1.39M | 0.02% | 690 |
|
|
2014
Q4 | $2.5M | Buy |
37,252
+6,725
| +22% | +$417K | 0.01% | 937 |
|
|
2014
Q3 | $1.65M | Buy |
30,527
+13,050
| +75% | +$642K | 0.01% | 926 |
|
|
2014
Q2 | $777K | Buy |
+17,477
| New | +$714K | ﹤0.01% | 1429 |
|
|
2014
Q1 | – | Sell |
-8,245
| Closed | -$237K | – | 2442 |
|
|
2013
Q4 | $237K | Buy |
+8,245
| New | +$239K | ﹤0.01% | 1959 |
|
Two Sigma Investments's CBPO Position: Q2 2021 in Review
Two Sigma Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 30,162 shares — an estimated $3.57M sold.
Two Sigma Investments first reported a position in CBPO in Q4 2013 and held it in 16 quarters. The position peaked at $25.8M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Two Sigma Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Two Sigma Investments sold 30,162 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $3.57M.
- Two Sigma Investments first reported a position in China Biologic Products Holdings, Inc. in Q4 2013 and held it in 16 quarters.
- Two Sigma Investments's China Biologic Products Holdings, Inc. position peaked at $25.8M in Q4 2020.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Two Sigma Investments's 13F filing for Q2 2021, filed 16 Aug 2021.